{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:42:36Z","timestamp":1790916156588,"version":"4.1.0"},"reference-count":35,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":2905,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To examine the long-term effects of type 1 diabetes treatment, metabolic control, and complications on health-related quality of life (HRQOL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A total of 1,441 participants, initially 13\u201339 years of age, were followed for an average of 23.5 years as part of the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) follow-up study. The Diabetes Quality-of-Life questionnaire (DQOL) was administered annually during DCCT and every other year during EDIC. Biomedical data, including HbA1c levels, exposure to severe hypoglycemia, intercurrent psychiatric events, and development of diabetes complications were collected at regular intervals throughout the follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Mean total DQOL scores were not significantly different between the former DCCT intensive and conventional treatment groups (DCCT baseline, 78 \u00b1 8 vs. 78 \u00b1 9; EDIC year 17, 75 \u00b1 11 vs. 74 \u00b1 11). Over the course of the study, a drop of \u22655 points in DQOL score from DCCT baseline maintained on two successive visits occurred in 755 individuals and was associated with increased HbA1c, albumin excretion rate, mean blood pressure, BMI, and occurrence of hypoglycemic events requiring assistance. Lower DQOL scores after 23.5 years of follow-up were associated with prior development of retinopathy (P = 0.0196), nephropathy (P = 0.0019), and neuropathy (P &amp;lt; 0.0001) as well as self-reported chest pain (P = 0.0004), decreased vision in both eyes (P = 0.0005), painful paresthesias (P &amp;lt; 0.0001), recurrent urinary incontinence (P = 0.0001), erectile dysfunction (P &amp;lt; 0.0001), and history of psychiatric events (P &amp;lt; 0.0001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Among DCCT\/EDIC participants, worsening metabolic control, serious diabetes complications and their associated symptoms, and development of psychiatric conditions led to decreased HRQOL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc12-2109","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T03:18:14Z","timestamp":1373339894000},"page":"3131-3138","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":139,"title":["The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life"],"prefix":"10.2337","volume":"36","author":[{"given":"Alan M.","family":"Jacobson","sequence":"first","affiliation":[{"name":"Winthrop University Hospital, Mineola, New York"},{"name":"Joslin Diabetes Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara H.","family":"Braffett","sequence":"additional","affiliation":[{"name":"The Biostatistics Center, George Washington University, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Cleary","sequence":"additional","affiliation":[{"name":"The Biostatistics Center, George Washington University, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose A.","family":"Gubitosi-Klug","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology, Diabetes & Metabolism, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Larkin","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DCCT\/EDIC Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,9,14]]},"reference":[{"key":"2022031221125122100_B1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4158\/EP.10.6.502","article-title":"Impact of improved glycemic control on quality of life in patients with diabetes","volume":"10","author":"Jacobson","year":"2004","journal-title":"Endocr Pract"},{"key":"2022031221125122100_B2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.19.3.195","article-title":"Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial","volume":"19","author":"Diabetes Control and Complications Trial Research Group","year":"1996","journal-title":"Diabetes Care"},{"key":"2022031221125122100_B3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.diabres.2007.12.020","article-title":"Disease-specific health-related quality of life instruments among adults diabetic: A systematic review","volume":"80","author":"El Achhab","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221125122100_B4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpedi.162.7.649","article-title":"Health-related quality of life of children and adolescents with type 1 or type 2 diabetes mellitus: SEARCH for Diabetes in Youth Study","volume":"162","author":"Naughton","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2022031221125122100_B5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpeds.2012.01.016","article-title":"Demographic and clinical correlates of diabetes-related quality of life among youth with type 1 diabetes","volume":"161","author":"Lawrence","year":"2012","journal-title":"J Pediatr"},{"key":"2022031221125122100_B6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diabet.2008.03.007","article-title":"A prospective study of quality of life in 77 type 1 diabetic patients 12 months after a hospital therapeutic educational programme","volume":"34","author":"Debaty","year":"2008","journal-title":"Diabetes Metab"},{"key":"2022031221125122100_B7","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2337\/dc07-0499","article-title":"Patient perceptions of quality of life with diabetes-related complications and treatments","volume":"30","author":"Huang","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031221125122100_B8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/TP.0b013e31818a7f45","article-title":"Improved long-term health-related quality of life after islet transplantation","volume":"86","author":"Tharavanij","year":"2008","journal-title":"Transplantation"},{"key":"2022031221125122100_B9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dia.2011.0162","article-title":"Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial","volume":"14","author":"Rubin","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"2022031221125122100_B10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1477-7525-10-48","article-title":"Hemoglobin A1c improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: a nested cohort study","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"2022031221125122100_B11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1464-5491.2008.02430.x","article-title":"Health utility values associated with diabetic retinopathy","volume":"25","author":"Lloyd","year":"2008","journal-title":"Diabet Med"},{"key":"2022031221125122100_B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bjo.2007.122416","article-title":"Vision-related quality of life in patients with diabetic macular oedema","volume":"92","author":"Hariprasad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"2022031221125122100_B13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00417-008-0960-y","article-title":"Diabetic retinopathy and health-related quality of life","volume":"247","author":"Davidov","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2022031221125122100_B14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1167\/iovs.11-8992","article-title":"The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes","volume":"53","author":"Fenwick","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022031221125122100_B15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.11.9.725","article-title":"Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT)","volume":"11","author":"The DCCT Research Group","year":"1988","journal-title":"Diabetes Care"},{"key":"2022031221125122100_B16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2337\/diacare.17.4.267","article-title":"The evaluation of two measures of quality of life in patients with type I and type II diabetes","volume":"17","author":"Jacobson","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031221125122100_B17","first-page":"65","article-title":"The diabetes quality-of-life measure","volume-title":"Handbook of Psychology and Diabetes","author":"Jacobson","year":"1994"},{"key":"2022031221125122100_B18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031221125122100_B19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/diacare.22.1.99","article-title":"Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031221125122100_B20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1464-5491.2009.02682.x","article-title":"Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes","volume":"26","author":"Speight","year":"2009","journal-title":"Diabet Med"},{"key":"2022031221125122100_B21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2022031221125122100_B22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"2022031221125122100_B23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"2022031221125122100_B24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1477-7525-6-87","article-title":"Evaluating the reliability, validity and minimally important difference of the Taiwanese version of the diabetes quality of life (DQOL) measurement","volume":"6","author":"Huang","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"2022031221125122100_B25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00007890-199107000-00018","article-title":"Long-term metabolic and quality of life results with pancreatic\/renal transplantation in insulin-dependent diabetes mellitus","volume":"52","author":"Nathan","year":"1991","journal-title":"Transplantation"},{"key":"2022031221125122100_B26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"2022031221125122100_B27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-122-8-199504150-00001","article-title":"The effect of intensive diabetes therapy on the development and progression of neuropathy","volume":"122","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Ann Intern Med"},{"key":"2022031221125122100_B28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ana.410380607","article-title":"Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial","volume":"38","author":"The Diabetes Control and Complications Trial (DCCT) Research Group","year":"1995","journal-title":"Ann Neurol"},{"key":"2022031221125122100_B29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diab.46.2.271","article-title":"Hypoglycemia in the Diabetes Control and Complications Trial","volume":"46","author":"The Diabetes Control and Complications Trial Research Group","year":"1997","journal-title":"Diabetes"},{"key":"2022031221125122100_B30","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study Research Group","year":"2007","journal-title":"N Engl J Med"},{"key":"2022031221125122100_B31","volume-title":"Statistical Methods","author":"Snedecor","year":"1989","edition":"8th ed."},{"key":"2022031221125122100_B32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","article-title":"Modern-day clinical course of type 1 diabetes mellitus after 30 years\u2019 duration: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)","volume":"169","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2009","journal-title":"Arch Intern Med"},{"key":"2022031221125122100_B33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1525-1497.1998.00243.x","article-title":"Living with hypoglycemia","volume":"13","author":"Ritholz","year":"1998","journal-title":"J Gen Intern Med"},{"key":"2022031221125122100_B34","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/S0140-6736(09)60963-6","article-title":"Diabetes: finding \u201ca clean well-lighted place\u201d","volume":"373","author":"Jacobson","year":"2009","journal-title":"Lancet"},{"key":"2022031221125122100_B35","first-page":"120","article-title":"How poorer quality of life in adolescence predicts subsequent type 1 diabetes management and control","volume-title":"Patient Educ Couns","author":"Hilliard","year":"2013"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/10\/3131\/615900\/3131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/10\/3131\/615900\/3131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:16:17Z","timestamp":1647126977000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/36\/10\/3131\/30635\/The-Long-Term-Effects-of-Type-1-Diabetes-Treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,14]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,9,14]]},"published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc12-2109","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,14]]}}}